Autoantibodies in laryngeal cancer: detection and role as a biomarker
Laboratory Medicine · 2024
DOI: 10.1093/labmed/lmad117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laboratory Medicine, 2024. Verfasst von Thashani Gunasekera und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Zoology and Environment Sciences, Faculty of Science, University of Colombo, Sri Lanka. Hauptthemen laut MEDLINE: Laryngeal Neoplasms, Autoantibodies, Biomarkers, Tumor, Enzyme-Linked Immunosorbent Assay. Die Arbeit nennt 44 Literaturangaben. Gefördert von: University of Colombo.
Abstract (Originalsprache)
Objective
Diagnostic role of autoantibodies (AAb) as serological biomarkers has not been specifically investigated in laryngeal cancer (LC) previously. The study investigates the presence of anti-LC AAbs and their potential as a biomarker for early diagnosis of LC, to improve patient outcome.
Method
Anti-LC AAb levels were investigated in LC patients (n = 30) and healthy individuals (n = 30) by indirect enzyme-linked immunosorbent assay (ELISA). Patient AAb levels were analyzed with various clinical factors, primarily tumor stage.
Results
AAb levels were significantly higher in LC patients than in the control group (P = .019). The diagnostic performance of AAb-level testing for LC detection presented a sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of 70% each. The positive likelihood (LR+) and negative likelihood (LR−) ratios were 2.33 and 0.43, respectively. AAb levels were independent of cancer stage (P = .708), duration since first appearance of symptoms (P = .228), duration of medical attention (P = .231), and degree of risk-factor exposure (P = .478).
Conclusion
Significant level of AAbs could be detected among LC patients with good diagnostic performance, irrespective of stage. Thus, anti-LC AAbs reflect potential to be utilized as predictive biomarkers in early diagnostics of LC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Zoology and Environment Sciences, Faculty of Science, University of Colombo, Sri Lanka.
- Institute of Biochemistry, Molecular Biology and Biotechnology, University of Colombo, Sri Lanka.
- ENT/Head and Neck Cancer, District General Hospital Chilaw, Chilaw, Sri Lanka.
Förderung
- University of Colombo
Zitieren
APA
Gunasekera, T., Rajagopalan, U., Herath, S., Samarakoon, S., Sakkaff, R., & Jalaldeen, R. (2024). Autoantibodies in laryngeal cancer: detection and role as a biomarker. Laboratory Medicine. https://doi.org/10.1093/labmed/lmad117
Vancouver
Gunasekera T, Rajagopalan U, Herath S, Samarakoon S, Sakkaff R, Jalaldeen R. Autoantibodies in laryngeal cancer: detection and role as a biomarker. Laboratory Medicine. 2024. doi:10.1093/labmed/lmad117
BibTeX
@article{Gunasekera2024,
author = {Gunasekera, Thashani and Rajagopalan, Umapriyatharshini and Herath, Samith and Samarakoon, Sameera and Sakkaff, Rizny and Jalaldeen, Roshan},
title = {Autoantibodies in laryngeal cancer: detection and role as a biomarker},
journal = {Laboratory Medicine},
year = {2024},
doi = {10.1093/labmed/lmad117}
}
EUVIMED